PF-00477736

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NamePF-00477736

Drug Alias NamePF-736PF-477736PF-0477736PF-00477736

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCheckpoint kinase 1 inhibitors

TargetsCheckpoint kinase 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A